multiple sclerosis

Celgene Reports Positive Results from New Analyses of Ozanimod in Multiple Sclerosis
Wed, 10/10/18 - 09:50 am
Celgene
ozanimod
multiple sclerosis
Novartis bets PRV on its next big multiple sclerosis drug — eyes US, EU approvals in ’19
Endpoints
Mon, 10/8/18 - 10:45 am
Novartis
siponimod
MS
multiple sclerosis
Europe
Servier drops GeNeuro’s multiple sclerosis drug after midphase miss
Fierce Biotech
Tue, 09/18/18 - 09:48 am
Servier
GeNeuro
MS
multiple sclerosis
GNbAC1
Federal court rules Ampyra patents invalid, Acorda stock sinks 25%
Biopharma Dive
Mon, 09/10/18 - 11:54 pm
Acorda Therapeutics
MS
multiple sclerosis
AMPYRA
patents
MS Society protests NICE rejection of Ocrevus for primary progressive MS
BioCentury
Mon, 09/10/18 - 12:16 am
NICE
UK
MS
multiple sclerosis
Ocrevus
ocrelizumab
Roche
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst
Fierce Pharma
Fri, 08/31/18 - 11:44 pm
Biogen
Teva Pharmaceutical
MS
multiple sclerosis
payers
Analyst sees positive future for Merck KGaA in MS market, as FDA accepts Mavenclad for review
The Pharma Letter
Wed, 08/1/18 - 10:43 am
Merck KGaA
Mavenclad
cladribine
MS
multiple sclerosis
Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Medical Marketing and Media
Wed, 07/18/18 - 10:49 pm
Celgene
Novartis
ozanimod
Gilenya
MS
multiple sclerosis
patents
Roche's multiple sclerosis drug Ocrevus lowered patients' vaccine responses: study
Fierce Pharma
Wed, 06/6/18 - 09:32 pm
Roche
MS
multiple sclerosis
Ocrevus
FDA
vaccines
Celgene's timeline for refiling ozanimod gets mixed reviews
Biopharma Dive
Sat, 05/5/18 - 10:58 am
Celgene
ozanimod
MS
multiple sclerosis
FDA
A metabolite will make or break Celgene's ozanimod
Biopharma Dive
Sat, 04/28/18 - 11:53 am
Celgene
ozanimod
MS
multiple sclerosis
metabolite
Celgene's Ozanimod Reduces Relapses and Brain Volume Loss in MS Patients in Phase III Trials
Tue, 04/24/18 - 09:25 am
Celgene Corporation
multiple sclerosis
ozanimod
Lemtrada Treatment Effects in MS Patients Maintained Over Seven Years
Tue, 04/24/18 - 02:29 pm
Lemtrada
Sanofi
Relapsing Remitting Multiple Sclerosis
multiple sclerosis
Roche Acquires MS Remyelination Program from Versant Ventures
CP Wire
Wed, 04/4/18 - 08:52 am
Roche
MS
multiple sclerosis
remylination
M&A
Versant Ventures
Inception 5
Roche Acquires MS Remyelination Program from Versant Ventures
Wed, 04/4/18 - 08:50 am
Roche
Versant Ventures
multiple sclerosis
Novartis' Siponimod significantly improved outcomes in PhIII data published in Lancet
CP Wire
Fri, 03/23/18 - 12:55 am
Novartis
siponimod
clinical trials
MS
multiple sclerosis
SPMS
Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
Endpoints
Fri, 03/2/18 - 11:08 am
Biogen
AbbVie
MS
multiple sclerosis
Zinbryta
Europe
encephalitis
Celgene stumbles again, as FDA declines to review multiple sclerosis drug critical to company future
Stat
Tue, 02/27/18 - 06:47 pm
Celgene
FDA
MS
multiple sclerosis
ozanimod
Novartis, Momenta grab a delayed FDA OK for blockbuster Copaxone knockoff
Endpoints
Tue, 02/13/18 - 09:11 am
Novartis
Momenta Pharmaceuticals
FDA
Copaxone
Teva Pharmaceutical
Glatopa
MS
multiple sclerosis
Will Teva Pharmaceutical's Pain Be Mylan's Gain?
Motley Fool
Fri, 02/9/18 - 09:33 am
Teva Pharmaceutical
Mylan Labs
Copaxone
generics
MS
multiple sclerosis

Pages